Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...

Hims wasn’t stepping back enough from its practice of mass marketing compounded versions of the weight-loss medicine, said ...

The U.S. Health and Human services secretary RFK Jr. will be in Baton Rouge at the end of the week for a bill signing with ...

Once-weekly amycretin, a novel peptide activating GLP-1, amylin, and calcitonin receptors, produced rapid, substantial, and ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.